Ryan Pelletier

University of Waterloo - Waterloo / Canada

Others

AD Scientific Index ID: 5590025

Registration, Add Profile,
Premium Membership

Print Your Certificate

Ryan Pelletier's MOST POPULAR ARTICLES

1-) Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviewsR Pelletier, K Ng, W Alkabbani, Y Labib, N Mourad, JM GambleTherapeutic Advances in Drug Safety 12, 2042098621989134, 2021612021

2-) The association of sodium‐glucose cotransporter 2 inhibitors with cancer: an overview of quantitative systematic reviewsR Pelletier, K Ng, W Alkabbani, Y Labib, N Mourad, JM GambleEndocrinology, Diabetes & Metabolism 3 (3), e00145, 2020252020

3-) Drug–drug interaction of the sodium glucose co-transporter 2 inhibitors with statins and myopathy: a disproportionality analysis using adverse events reporting dataW Alkabbani, R Pelletier, MA Beazely, Y Labib, B Quan, JM GambleDrug Safety 45 (3), 287-295, 2022132022

4-) Sodium/glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis: an example of complementary evidence for rare adverse eventsW Alkabbani, R Pelletier, JM GambleAmerican Journal of Epidemiology 190 (8), 1572-1581, 2021152021

5-) Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an …R PelletierJournal of Oncology Pharmacy Practice 27 (4), 911-918, 202142021

ARTICLES

Add your articles